Central Nervous System Neoplasms: Clinical Trials

3,427 trials for Central Nervous System Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1531 completed, 542 recruiting, 405 unknown, 396 terminated. 1109 Phase 2, 866 Phase 1, 696 Not applicable, 206 Phase 3, 88 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 21109Completed 515, Terminated 160, Recruiting 142, Unknown 118, Active not recruiting 80, Withdrawn 54, Not yet recruiting 33, Suspended 7
Phase 1866Completed 453, Terminated 132, Recruiting 109, Active not recruiting 70, Withdrawn 42, Unknown 35, Not yet recruiting 18, Suspended 7
Not applicable696Completed 249, Recruiting 159, Unknown 105, Terminated 56, Active not recruiting 39, Not yet recruiting 39, Withdrawn 35, Suspended 8, Enrolling by invitation 6
Phase 3206Completed 96, Unknown 36, Recruiting 23, Terminated 19, Active not recruiting 18, Not yet recruiting 9, Withdrawn 5
Early Phase 188Completed 32, Terminated 17, Recruiting 16, Not yet recruiting 7, Active not recruiting 6, Withdrawn 6, Unknown 3, Enrolling by invitation 1
Phase 464Completed 31, Unknown 14, Recruiting 9, Terminated 4, Active not recruiting 2, Enrolling by invitation 2, Not yet recruiting 1, Withdrawn 1

Follow Central Nervous System Neoplasms: new trials by email Literature Review of Central Nervous System Neoplasms trials Research Report on Central Nervous System Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas
RNS System Implantation - Glioma, Glioma Intracranial
Not applicableNot yet recruitingMedical College of Wisconsin32028-08-012026-10-13
Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma
JBI-778 - Brain Metastases From Solid Tumors, Leptomeningeal Disease
Phase 1 / Phase 2Not yet recruitingJubilant Therapeutics Inc.1132028-04-012026-08-07
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
Aminolevulinic acid hydrochloride - Pediatric Brain Tumor
Phase 2Not yet recruitingCostas Hadjipanayis202027-08-012026-10-07
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
H3K27M-EIEs - Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-10-30
Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements
Non-Interventional Study - Brain Tumor, Recurrent Brain Tumor
Not yet recruitingMayo Clinic302027-06-012026-09-16
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG
Opdualag - High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2Not yet recruitingNationwide Children's Hospital122027-03-012026-09-09
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Tovorafenib - High Grade Glioma (HGG) of the Brain With BRAF Aberration, High Grade Glioma (III or IV)
Phase 2Not yet recruitingNationwide Children's Hospital792027-02-012026-10-20
IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas
IDH1-vac, IS-vac, Temozolomide (TMZ) - Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4
Phase 2Not yet recruitingGerman Cancer Research Center2162027-02-012026-10-22
Blood Brain Barrier Dysfunction in Glioma and Epileptogenesis
Epilepsy, Glioma
Not yet recruitingUniversity College, London562027-01-042026-11-02
Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults
Mirdametinib - LGCMN, Large and Giant Congenital Melanocytic Nevi
Phase 2Not yet recruitingNational Cancer Institute (NCI)152027-01-042026-10-29
Ceritinib Treatment for Recurrent Meningiomas
Ceritinib - Recurrent Meningioma, Grade I and Grade II
Phase 2Not yet recruitingKevin Petrecca102027-01-012026-10-23
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Trastuzumab Deruxtecan, Stereotactic Radiosurgery - Breast Cancer, HER2-positive Breast Cancer
Phase 1Not yet recruitingBaptist Health South Florida202027-01-012026-10-01
Listen Aphasia Pilot Study
LISTEN (AI-based AAC smartphone app) - Aphasia, Malignant Brain Tumor
Not applicableNot yet recruitingDana-Farber Cancer Institute802027-01-012026-07-28
A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar Spine
3D-printed custom-made non-rigid biomimetic implant - Spinal Tumor
Not applicableNot yet recruitingNational Taiwan University Hospital182027-01-012025-12-17
ctDNA-Guided Intraventricular Therapy for CNS Malignancies
CSF ctDNA-Guided Clinical Management - Leptomeningeal Disease, Glioblastoma
Not applicableNot yet recruitingAlireza Mansouri772027-01-012026-07-08
DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)
Dexmedetomidine, Normal Saline (0.9% NaCl) - Neurosurgery, Brain Cancer
Not applicableNot yet recruitingUniversity of Malaya602027-01-012026-11-05
rTMS for Postoperative Brain Tumor Patients
Transcranial magnetic stimulation (TMS) - Brain Tumors, Transcranial Magnetic Stimulation
Not applicableRecruitingBrian J.Gill62027-01-012026-10-29
Remimazolam vs Propofol for Motor and Somatosensory Evoked Potentials in Spinal Tumor Surgery
Remimazolam, Propofol - Spinal Cord Neoplasms, Spinal Neoplasms
Phase 4Not yet recruitingBeijing Tsinghua Chang Gung Hospital1902027-01-012026-10-28
IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)
Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells - High-grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 1Not yet recruitingUniversity of Florida242027-01-012026-10-30
Immune Modulatory DC Vaccine Against Brain Tumor
Immunomodulatory DC vaccine to target DIPG and GBM - Diffuse Intrinsic Pontine Glioma or Glioblastoma
Phase 1Not yet recruitingShenzhen Geno-Immune Medical Institute102026-12-312026-10-30

Showing 20 of 3427. Sign in to see all of them.

Narrower conditions

Brain Neoplasms (2373)  ·  Glioblastoma (731)  ·  Glioma (597)  ·  Astrocytoma (444)  ·  Gliosarcoma (364)  ·  Oligodendroglioma (306)  ·  Neoplasms (251)  ·  Meningioma (241)  ·  Breast Neoplasms (219)  ·  Medulloblastoma (204)  ·  Carcinoma, Non-Small-Cell Lung (193)  ·  Pituitary Neoplasms (192)  ·  Neoplasm Metastasis (171)  ·  Ependymoma (168)

Broader conditions

Nervous System Diseases (3415)  ·  Nervous System Neoplasms (3415)  ·  Neoplasms by Site (3414)  ·  Neoplasms (3176)  ·  Central Nervous System Diseases (2827)  ·  Brain Diseases (2745)  ·  Neoplasms by Histologic Type (1711)  ·  Neoplasms, Nerve Tissue (1549)  ·  Neuroectodermal Tumors (1422)  ·  Neoplasms, Germ Cell and Embryonal (1416)  ·  Neoplasms, Glandular and Epithelial (1359)  ·  Neoplasms, Neuroepithelial (1263)  ·  Glioma (632)  ·  Pathological Conditions, Signs and Symptoms (502)

Interventions

Temozolomide (256)  ·  Radiotherapy (224)  ·  Radiosurgery (145)  ·  Bevacizumab (126)  ·  Magnetic Resonance Spectroscopy (113)  ·  Carboplatin (89)  ·  Cyclophosphamide (65)  ·  Etoposide (62)  ·  Filgrastim (55)  ·  Vincristine (55)  ·  Cisplatin (54)  ·  Irinotecan (53)  ·  Nivolumab (46)  ·  Surgical Procedures, Operative (46)  ·  Radiation (45)

Sponsors

National Cancer Institute (NCI) (194)  ·  M.D. Anderson Cancer Center (113)  ·  Duke University (78)  ·  Memorial Sloan Kettering Cancer Center (72)  ·  Children's Oncology Group (49)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (48)  ·  St. Jude Children's Research Hospital (44)  ·  Mayo Clinic (43)  ·  Case Comprehensive Cancer Center (33)  ·  Massachusetts General Hospital (33)  ·  European Organisation for Research and Treatment of Cancer - EORTC (30)  ·  City of Hope Medical Center (28)  ·  Jonsson Comprehensive Cancer Center (28)  ·  Dana-Farber Cancer Institute (26)  ·  Beijing Tiantan Hospital (25)

Countries

United States (1986)  ·  China (289)  ·  Canada (270)  ·  France (253)  ·  Germany (161)  ·  Italy (145)  ·  United Kingdom (142)  ·  Netherlands (124)  ·  Australia (110)  ·  Switzerland (104)  ·  Spain (103)  ·  Belgium (83)  ·  South Korea (76)  ·  Taiwan (65)  ·  Austria (56)

Top investigators

Henry S. Friedman, MD (19)  ·  Stuart A. Grossman, MD (13)  ·  David A. Reardon, MD (11)  ·  John Boockvar, MD (10)  ·  Maryam Fouladi, MD (10)  ·  Amar Gajjar, MD (9)  ·  Jeffrey J. Raizer, MD (9)  ·  Darell D. Bigner, MD, PhD (8)  ·  Katherine E Warren, M.D. (8)  ·  Roger Stupp, MD (8)  ·  David Peereboom, MD (7)  ·  Edward G. Shaw, MD (7)  ·  Jonathan L. Finlay, MB, ChB (7)

Results publications

PMID 34081125, PMID 31401903, PMID 19801201, PMID 16757720, PMID 23545055, PMID 25349290, PMID 27243238, PMID 27458945, PMID 30118397, PMID 31809241, PMID 41213248, PMID 14722039, PMID 15117425, PMID 15758009, PMID 16200343, PMID 16648043, PMID 17705175, PMID 19556464, PMID 20694800, PMID 21041710, PMID 21584645, PMID 21865400, PMID 23243055, PMID 23377664, PMID 23956241, PMID 25098701, PMID 25113840, PMID 25209242, PMID 25303679, PMID 25614945, PMID 25789053, PMID 26148750, PMID 26334749, PMID 26827696, PMID 27488294, PMID 27744512, PMID 28039367, PMID 28592387, PMID 28640703, PMID 29077941, PMID 29122701, PMID 29151359, PMID 29343557, PMID 29982805, PMID 30059262, PMID 30670498, PMID 31062234, PMID 31587882, PMID 31838007, PMID 32058845

NIH funding

2023 (17), P30CA033572 (17), U01CA062475 (17), U01CA081457 (16), U10CA180886 (14), P30CA043703 (12), 2015 (11), P30CA138292 (11), UM1CA097452 (11), 2014 (10), P30CA006973 (10), U01CA062399 (10), U01CA137443 (10), U10CA098543 (10), UM1CA081457 (10)